Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117262) titled 'Study on the Efficacy and Safety of Primidone in Adult with Amyotrophic Lateral Sclerosis - A Randomized, Double-blind, Placebo-controlled Clinical Trial' on Jan. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Yichang Central People's Hospital
Condition:
Amyotrophic lateral sclerosis
Intervention:
Primidone treatment group:Primidone
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-30
Target Sample Size: Primidone treatment group:192;Placebo group:96;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj....